Dashboard
Manage Tickers

ELTXElicio Therapeutics, Inc.

Nasdaq elicio.com


$ 10.71 $ 0.00 (0 %)    

Thursday, 16-May-2024 09:32:28 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 453.41 $ -0.06 (-0.01 %)
DIA $ 399.45 $ -0.19 (-0.05 %)
SPY $ 530.20 $ 0.29 (0.06 %)
TLT $ 92.12 $ -0.26 (-0.29 %)
GLD $ 219.89 $ -0.12 (-0.05 %)
$ 10.4
$ 10.71
$ 0.00 x 0
$ 0.00 x 0
$ 10.71 - $ 10.71
$ 2.96 - $ 22.65
45,104
na
106.85M
$ 1.80
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 03-29-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-12-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
6 03-17-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-16-2022 03-31-2022 10-Q
10 03-30-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-17-2021 03-31-2021 10-Q
14 03-30-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

elicio-therapeutics-q1-2024-adj-eps-115-misses-109-estimate
Elicio Therapeutics Q1 2024 Adj EPS $(1.15...
05/15/2024 20:50:04

Elicio Therapeutics (NASDAQ:ELTX) reported quarterly losses of $(1.15) per share which missed the analyst consensus estimate of...

hc-wainwright--co-maintains-buy-on-elicio-therapeutics-lowers-price-target-to-10
HC Wainwright & Co. Maintains Buy on Elici...
05/01/2024 10:25:43

HC Wainwright & Co. analyst Robert Burns maintains Elicio Therapeutics (NASDAQ:ELTX) with a Buy and lowers the price tar...

elicio-therapeutics-to-present-new-preliminary-data-from-the-ongoing-amplify-7p-phase-12-study-of-eli-002-7p-in-patients-with-mkras-driven-solid-tumors-at-the-2024-asco-annual-meeting
Elicio Therapeutics To Present New Prelimi...
04/25/2024 12:41:41

Elicio Therapeutics, Inc. (NASDAQ:ELTX, "Elicio Therapeutics" or "Elicio")))), a clinical-stage biotechnology c...

elicio-therapeutics-to-present-updated-clinical-t-cell-and-antigen-spreading-response-data-from-the-ongoing-amplify-201-phase-1-study-of-eli-002-and-preclinical-data-on-eli-007-and-eli-008-at-the-aacr-annual-meeting
Elicio Therapeutics To Present Updated Cli...
04/05/2024 20:34:29

68% of patients treated with ELI-002 developed cytotoxic mKRAS-specific CD4+ T cells 84% of patients treated with ELI-002 devel...

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
04/05/2024 20:31:09

oppenheimer-reiterates-perform-on-elicio-therapeuticsto-perform
Oppenheimer Reiterates Perform on Elicio T...
04/01/2024 13:21:15

Oppenheimer analyst Matthew Biegler reiterates Elicio Therapeutics (NASDAQ:ELTX) from Perform to Perform.

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
03/18/2024 17:31:33

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
03/18/2024 13:05:55

elicio-therapeutics-announces-60m-private-placement-financing-to-purchase-up-to-1032702-shares-at-581-per-pre-funded-warrant
Elicio Therapeutics Announces $6.0M Privat...
03/18/2024 12:07:26

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
02/08/2024 13:05:59

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
02/07/2024 17:31:16

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
02/07/2024 13:06:01

elicio-therapeutics-dosed-first-patient-in-phase-2-study-of-eli-002-7p
Elicio Therapeutics Dosed First Patient In...
02/01/2024 13:47:31

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
01/29/2024 13:06:03

elicio-therapeutics-publishes-preclinical-data-demonstrating-tcr-t-cell-therapy-in-combination-with-lymph-node-targeted-amphiphile-immunotherapy-enhanced-anti-tumor-function-and-eradicated-solid-tumors
Elicio Therapeutics Publishes Preclinical ...
01/25/2024 14:01:47

Published data shows lymph node-targeted Amphiphile ("AMP")-peptide and CpG combination with TCR-T cell therapy led to ...

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
01/24/2024 17:31:02

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
01/22/2024 17:31:11

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
01/19/2024 21:31:09

elicio-therapeutics-to-present-eli-002-7p-trial-in-progress-poster-on-phase-12-study-of-lymph-node-targeted-vaccine-at-asco-gi-symposium
Elicio Therapeutics To Present ELI-002 7P ...
01/17/2024 13:33:20

AMPLIFY-7P study builds on preliminary positive findings from the 2-peptide formulation of ELI-002 published in Nature Medicine...

hc-wainwright--co-maintains-buy-on-elicio-therapeutics-raises-price-target-to-11
HC Wainwright & Co. Maintains Buy on Elici...
01/17/2024 11:25:02

HC Wainwright & Co. analyst Robert Burns maintains Elicio Therapeutics (NASDAQ:ELTX) with a Buy and raises the price tar...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION